Skip navigation

 Login or Register | Member Centre

Posted AT 8:56 AM EST on 17/04/08

Angiotech gets FDA go-ahead to market vein catheter

The Canadian Press

Angiotech Pharmaceuticals, Inc. said Thursday it has received approval from the U.S. Food and Drug Administration to market its 5-Fluorouracil-coated central venous catheter in the United States. The device, also known as 5-FU CVC, is the first to be completely researched and developed in-house by the Vancouver company.

The full text of this article has 240 words.

To continue reading this article, you will need to purchase this article.

Already have a member account? Login now

Pay-Per-View Offers To read the complete article, select one of the following options

Purchasing from globeandmail.com is quick and secure.

Single Article: $4.95

4-pack: $17.95

Back to top